Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

Journal of Hepatology

Volumn 19, Issue 3, 1993, Pages 408-412

  Camps, Joan ^a   García, Nicolás ^a   Riezu Boj, José I ^a   Civeira, María P ^a   Prieto, Jesús ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Aminotransferases; Cirrhosis; Hepatitis C virus RNA; Viral replication

Indexed keywords

ALPHAN1 INTERFERON; RIBAVIRIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS NON A NON B; HUMAN; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMAN; INTERFERON-ALPHA; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; RIBAVIRIN; SUPPORT, NON-U.S. GOV'T; TRANSAMINASES;

EID: 0027762814     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(05)80550-1     Document Type: Article

References (32)

1. The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis
2. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
3. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
4. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis
5. Chronic consequences of non-A, non-B hepatitis
6. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
7. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
8. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
9. Hepatitis C virus antibodies among risk groups in Spain
10. Treatment of chronic type C hepatitis with alpha interferon
11. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C
12. Broad-spectrum activity of virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide
13. Inhibition of hepatitis A virus replication in vitro by antiviral compounds
14. Inhibition of hepatitis delta virus RNA replication in primary woodchuck hepatocytes
15. Antiviral strategies in chronic hepatitis B virus infections
16. Molecular mechanisms of action of ribavirin
17. Studies on the mechanism of the antiviral activity of ribavirin against reovirus
18. Evaluation of ribavirin in the treatment of acute hepatitis
19. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations
20. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis
21. Lassa Fever
22. Ribavirin treatment for chronic hepatitis C
23. Detection of hepatitis C viral sequences in blood donations by ‘nested’ polymerase chain reaction and prediction of infectivity
24. Enhanced detection by PCR of hepatitis C virus RNA
25. The 5′-terminal sequence of the hepatitis C virus genome
26. Avoiding false positives with PCR
27. Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses
28. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction
29. Inhibition of murine plaque-forming cell responses in vivo by ribavirin
30. Staff editorial
31. Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1
32. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro